Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia

Eleni Tholouli; Effie Liakopoulou; Hayley M Greenfield; Bronwen E Shaw; Sudhir Tauro; Jennifer L Byrne; Mike Dennis; John Burthem; Guy S Lucas; Charles Craddock; Nigel H Russell; John A Liu Yin

doi:10.1111/j.1365-2141.2008.07184.x

Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia

Eleni Tholouli
, Effie Liakopoulou
, Hayley M Greenfield
, Bronwen E Shaw
, Sudhir Tauro
, Jennifer L Byrne
, Mike Dennis
, John Burthem
, Guy S Lucas
, Charles Craddock
, Nigel H Russell
, John A Liu Yin

Cancer Research UK Clinical Trials Unit

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Original language	English
Pages (from-to)	318-20
Number of pages	3
Journal	British Journal of Haematology
Volume	142
Issue number	2
DOIs	https://doi.org/10.1111/j.1365-2141.2008.07184.x
Publication status	Published - 2008

Access to Document

10.1111/j.1365-2141.2008.07184.x

Cite this

Tholouli, E., Liakopoulou, E., Greenfield, H. M., Shaw, B. E., Tauro, S., Byrne, J. L., Dennis, M., Burthem, J., Lucas, G. S., Craddock, C., Russell, N. H., & Liu Yin, J. A. (2008). Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia. British Journal of Haematology, 142(2), 318-20. https://doi.org/10.1111/j.1365-2141.2008.07184.x

@article{5f85994a2427403493ed20fa7ab76456,

title = "Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia",

author = "Eleni Tholouli and Effie Liakopoulou and Greenfield, \{Hayley M\} and Shaw, \{Bronwen E\} and Sudhir Tauro and Byrne, \{Jennifer L\} and Mike Dennis and John Burthem and Lucas, \{Guy S\} and Charles Craddock and Russell, \{Nigel H\} and \{Liu Yin\}, \{John A\}",

year = "2008",

doi = "10.1111/j.1365-2141.2008.07184.x",

language = "English",

volume = "142",

pages = "318--20",

journal = "British Journal of Haematology",

issn = "1365-2141",

publisher = "Wiley",

number = "2",

}

Tholouli, E, Liakopoulou, E, Greenfield, HM, Shaw, BE, Tauro, S, Byrne, JL, Dennis, M, Burthem, J, Lucas, GS, Craddock, C, Russell, NH & Liu Yin, JA 2008, 'Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia', British Journal of Haematology, vol. 142, no. 2, pp. 318-20. https://doi.org/10.1111/j.1365-2141.2008.07184.x

TY - JOUR

T1 - Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia

AU - Tholouli, Eleni

AU - Liakopoulou, Effie

AU - Greenfield, Hayley M

AU - Shaw, Bronwen E

AU - Tauro, Sudhir

AU - Byrne, Jennifer L

AU - Dennis, Mike

AU - Burthem, John

AU - Lucas, Guy S

AU - Craddock, Charles

AU - Russell, Nigel H

AU - Liu Yin, John A

PY - 2008

Y1 - 2008

U2 - 10.1111/j.1365-2141.2008.07184.x

DO - 10.1111/j.1365-2141.2008.07184.x

M3 - Article

C2 - 18492100

SN - 1365-2141

VL - 142

SP - 318

EP - 320

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 2

ER -